.svg)
FAIRFIELD, Iowa, March 15, 2017 — Hedge funds were up 0.99% in February according to the Barclay Hedge Fund Index compiled by BarclayHedge. The Index is up 2.38% after two months in 2017, its best start since 2013 when it gained 2.77% by the end of February.
All 17 of Barclay’s hedge fund indices recorded gains in February. The Technology Index was up 2.62%, Healthcare and Biotechnology gained 2.51%, Equity Long Bias was up 1.69%, Emerging Markets gained 1.47%, and the Event Driven Index added 1.30%.
“Positive economic indicators in the US, Europe and China helped to propel the global equity rally into its fourth consecutive month of gains,” says Sol Waksman, founder and president of BarclayHedge.
At the end of February, all of Barclay’s hedge fund indices are in positive territory for the year.
The Technology Index has gained 5.20%, Healthcare and Biotechnology is up 4.84%, Emerging Markets have gained 4.14%, the Event Driven Index is up 3.40%, Equity Long Bias has gained 3.00%.
The Barclay Fund of Funds Index gained 0.80% in February, and is up 1.67% in 2017.
Click here to view five years of Barclay Hedge Fund Index data, or to download 20 years of monthly data.
Sol Waksman is an experienced media source, providing perspectives on hedge fund and managed futures trends. For more commentary or background, call 641-472-3456 or email swaksman@barclayhedge.com.
BarclayHedge is the global leader in providing independent, research-based information services to the alternative investment industry. Founded in 1985, Barclay currently maintains data on more than 6,400 hedge funds, fund of funds, and CTAs. No one has been in the business of collecting alternative investment data longer than BarclayHedge.
Institutional investors, brokerage firms, and private banks worldwide utilize BarclayHedge indices as performance benchmarks for the hedge fund and managed futures industries.
